Filed March 9, 2026

Serial No. 79460170

Examining Attorney GRACE M DUFFIN

Class Medicinal preparations and substances; pharmaceuticals and natural remedies; pharmaceutical drugs; pharmaceutical products and preparations; diagnostic preparations and materials, for medical and veterinary purposes; diagnostic agents for pharmaceutical use; therapeutic companion diagnostics in the form of reagents for assisting with predicting the effects of medication, the existence or non-existence of side effects and with selecting medication to be administered relating to the respective patient; in vitro diagnostic preparations, in particular reagents, solutions and test strips for analysing biological samples for clinical use and for medical and diagnostic purposes; reagents, solutions and test strips for medical and clinical use; diagnostic reagents for medical use, for analysing body fluids, in particular saliva and blood; test strips for detecting substances in body fluids, in particular saliva and blood, for laboratory use and for medical use; compounds, in particular active substances and/or reagents, materials and preparations for clinical diagnostics or therapeutic companion diagnostics; chemical preparations for use in medical diagnostics, in particular preparations for personalised medicine and/or gene analysis and/or genome sequencing; chemical preparations for use in rna, dna and antibody analysis, in particular in the field of personalised medicine; ready-to-use injections filled with pharmaceutical preparations; dietary supplements and dietetic preparations; pharmaceutical agents affecting digestive organs; pharmaceutical agents affecting metabolism; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of inflammatory and bacterial diseases; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention of bacterial disorders; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of immune system disorders and autoimmune disorders; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for immune system adjustment; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for regulating the immune system; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of digestive system diseases and disorders; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of hypertension; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for activating cell function; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the peripheral nervous system; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of kidney diseases and disorders; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of liver diseases; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of metabolic disorders and diseases; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of skin disorders and problems; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of bone diseases; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of rheumatic diseases; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of depression; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention and treatment of musculoskeletal diseases; pharmaceuticals and pharmaceutical preparations, the aforesaid goods for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for use in organ transplantation; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for use in dermatology; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for use in urology; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the treatment of hypercholesterolemia; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the treatment of hyperlipidemia; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the prevention of osteoporosis; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the treatment of the digestive tract, including the oesophagus; pharmaceutical preparations and pharmaceuticals, namely capsules, powders, tablets, sachets, juices, suspensions, granules, enema preparations, suppositories and suppositories [for rectal application], rectal foam for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; drug delivery agents that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, in particular including plant-based preparations, and preparations for the treatment of constipation, coeliac disease, haemorrhoids, pancreatitis [in particular acute pancreatitis], high cholesterol, zinc deficiency, irritable bowel syndrome or supportive therapies for diarrhoea; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for intestinal cleansing before a colonoscopy; immunosuppressants and cortisol preparations for the treatment of organ transplants, inflammatory bowel disease, skin diseases and rheumatic joint inflammation; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for supporting the body in connection with an organ transplant; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the treatment of rheumatoid arthritis, chronic inflammatory bowel disease, in particular crohn's disease or ulcerative colitis, systemic lupus erythematosus, dermatomyositis, polymyositis, chronic active autoimmune hepatitis, polyarteritis nodosa, autoimmune haemolytic anaemia, chronic refractory idiopathic thrombocytopenic purpura; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the treatment of chronic intestinal inflammation, in particular microscopic colitis, chronic inflammation of the liver [autoimmune hepatitis] and inflammatory diseases of the oesophagus [eosinophilic oesophagitis]; pharmaceutical preparations and pharmaceuticals, the aforesaid goods for the dissolving of gallstones, for the treatment of chronic diseases of the biliary tract and for the treatment of liver diseases, in particular cirrhosis of the liver or liver disease in connection with cystic fibrosis [mucoviscidosis]; pre-filled syringes for medical purposes; autoinjectors for the administration of pharmaceutical preparations.; 005; 006; 018; 044; 046; 051; 052; 026; 039; 044; 002; 005; 022; 023; 029; 037; 038; 050; 100; 101; 102; 100; 101; 107; 100; 101; 100; 101

Case Type Trademark Service mark